| Registry | NCT01338402 |
|---|---|
| Status | Completed |
| Phase | Not applicable |
| Study type | Interventional; randomized, single group, masking: single |
| Enrollment | 47 (Actual) |
| Sponsor | CIBA VISION (Industry); collaborators: University of Waterloo |
| Conditions | Myopia |
| Interventions | Lotrafilcon B contact lens, Lotrafilcon B contact lens with color, Phemfilcon A contact lens with color (Device) |
| Dates | start 2011-04-01, primary completion 2012-03-01, completion 2012-03-01, first posted 2011-04-19, last updated 2014-02-20 |
| Locations | 1 site in Canada |
Related Papers Related Patents Related Grants Related Experts
All trials for Myopia All trials of Lotrafilcon B contact lens All trials of Lotrafilcon B contact lens with color
The purpose of this study was to assess the ocular response to and performance of the cosmetically printed silicone hydrogel contact lens AIR OPTIX® COLORS compared to FRESHLOOK® COLORBLENDS.
The study was conducted in two phases. Phase 1 was an adaptation phase where participants wore AIR OPTIX® AQUA contact lenses bilaterally (same product in both eyes) on a daily wear basis for 1 week. In Phase 2, participants wore AIR OPTIX® COLORS and FRESHLOOK® COLORBLENDS contact lenses contralaterally (different product in each eye) on a daily wear basis for 4 weeks.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| AIR OPTIX® AQUA | Other | Device: Lotrafilcon B contact lens | Lotrafilcon B contact lenses worn in both eyes on a daily wear basis for one week in Phase 1. |
| AIR OPTIX® COLORS | Experimental | Device: Lotrafilcon B contact lens with color | Lotrafilcon B contact lens with color randomly assigned to one eye, with phemfilcon A contact lens with color in the fellow eye for contralateral wear. Both products worn on a daily wear basis for 4 weeks in Phase 2. A replacement phemfilcon A lens was dispensed at the Week 2 visit. |
| FRESHLOOK® COLORBLENDS | Active comparator | Device: Phemfilcon A contact lens with color | Phemfilcon A contact lens with color randomly assigned to one eye, with lotrafilcon B contact lens with color in the fellow eye for contralateral wear. Both products worn on a daily wear basis for 4 weeks in Phase 2. A replacement phemfilcon A lens was dispensed at the Week 2 visit. |
Sex: All, ages: 17 Years to any
Inclusion Criteria: * Full legal capacity to volunteer; * Read and sign information and consent letter; * Willing and able to follow instructions and maintain the appointment schedule; * Ocular examination in the last two years; * Currently wears soft contact lenses on a daily wear basis; * Contact lens prescription between -1.50 diopters and -5.00 diopters; * Other protocol-defined inclusion criteria may apply. Exclusion Criteria: * Any ocular disease; * Any systemic condition that may affect a study outcome variable; * Any systemic or topical medications that may affect ocular health; * Known sensitivity to the diagnostic pharmaceuticals used in the study; * Unable to achieve an acceptable fit with the study lenses; * Anisometropia >1.00 diopter or astigmatism >0.75 diopter; * Use of lubricating/rewetting eye drops. * Other protocol-defined exclusion criteria may apply.
| Facility | City | Country | Status |
|---|---|---|---|
| Centre for Contact Lens Research, University of Waterloo | Waterloo, Ontario | Canada |